BNY Mellon Fund Managers Limited
Addresses
The contact details this firm has registered with the FCA.
-
Principal Place of Business
BNY Mellon Centre160 Queen Victoria StreetLondonEC4V 4LAUNITED KINGDOM- Phone
- +4402071635566
-
Complaints Contact
BNY Mellon Centre160 Queen Victoria StreetLondonEC4V 4LAUNITED KINGDOM- Phone
- +4402071632793
What this firm is allowed to do
The regulated activities the FCA has granted this firm permission to carry out.
-
Retail Investment Funds
-
Specialist Investment Funds
-
Private Investment Funds
Approved individuals
Senior staff personally approved by the FCA to hold their roles here.
-
Caylie Stallard
IRN CXS00668
- SMF1 Chief Executive (since 16 Jan 2026)
- SMF3 Executive Director (since 1 Feb 2023)
-
Chantal Sheehan
IRN CXS00889
- SMF16 Compliance Oversight (5 Nov 2024 to 12 Dec 2025)
-
Claire Louise Wallace
IRN CLW01099
- CF10 Compliance Oversight (9 Feb 2012 to 28 Dec 2012)
-
David Michael Turnbull
IRN DMT01115
- CF3 Chief Executive (12 Mar 2013 to 11 Apr 2019)
- CF10a CASS Oversight function (1 Oct 2011 to 5 Nov 2018)
- CF1 Director (1 Aug 2011 to 27 Mar 2019)
-
Elizabeth Roach
IRN EXR01231
- SMF16 Compliance Oversight (since 12 Dec 2025)
-
Gerald Rehn
IRN GXR01273
- Director of firm who is not a certification employee or a SMF manager (1 Feb 2023 to 9 Feb 2024)
- SMF3 Executive Director (9 Dec 2019 to 1 Feb 2023)
- SMF1 Chief Executive (9 Dec 2019 to 1 Feb 2023)
- CF3 Chief Executive (12 Jul 2019 to 8 Dec 2019)
- CF1 Director (11 Feb 2019 to 8 Dec 2019)
-
Graeme Whyte
IRN GXW01159
- CF1 Director (1 Dec 2001 to 19 Apr 2002)
-
Graham Stanley Chapman
IRN GSC01090
- CF28 Systems and controls (4 Feb 2011 to 9 Jun 2016)
-
Gregory Allan Brisk
IRN GAB01056
- Director of firm who is not a certification employee or a SMF manager (9 Dec 2019 to 2 Mar 2023)
- CF3 Chief Executive (19 Nov 2012 to 15 Feb 2013)
- CF1 Director (1 Nov 2002 to 9 Dec 2019)
- CF10 Compliance Oversight (1 Dec 2001 to 1 Nov 2002)
- CF11 Money Laundering Reporting (1 Dec 2001 to 1 Nov 2002)
- CF14 Risk Assessment (1 Dec 2001 to 1 Nov 2002)
-
HILARY Lopez
IRN HCL01021
- SMF3 Executive Director (9 Dec 2019 to 22 Mar 2021)
- CF1 Director (18 Feb 2016 to 8 Dec 2019)
Recent activity
Updates to this firm's record on the FCA register.
No changes recorded yet.